Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Crizotinib in refractory ALK-positive diffuse large B-cell lymphoma: a case report with a short-term response.

× No keyword cloud information.

11 in total

Review 1. ALK-positive large B-cell lymphoma: identification of EML4-ALK and a review of the literature focusing on the ALK immunohistochemical staining pattern.

Authors: Kana Sakamoto; Hideki Nakasone; Yuki Togashi; Seiji Sakata; Naoko Tsuyama; Satoko Baba; Akito Dobashi; Reimi Asaka; Chien-Chen Tsai; Shih-Sung Chuang; Koji Izutsu; Yoshinobu Kanda; Kengo Takeuchi
Journal: Int J Hematol Date: 2016-01-18 Impact factor: 2.490

2. Reduction of leukemia cell burden and restoration of normal hematopoiesis at 3 months of crizotinib treatment in RAN-binding protein 2 (RANBP2)-anaplastic lymphoma kinase (ALK) acute myeloid leukemia.

Authors: Y Maesako; A Okumura; K Takeoka; C Kishimori; K Izumi; Y Kamoda; F Iioka; T Akasaka; H Ohno
Journal: Leukemia Date: 2014-05-21 Impact factor: 11.528

Review 3. Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma presenting in nasal cavity: a case report and review of literature.

Authors: Ji Chen; Xiaoli Feng; Mei Dong
Journal: Int J Clin Exp Pathol Date: 2015-02-01

4. Promising response of anaplastic lymphoma kinase-positive large B-cell lymphoma to crizotinib salvage treatment: case report and review of literature.

Authors: Jian Li; Jian Ouyang; Rongfu Zhou; Bing Chen; Yong Xu
Journal: Int J Clin Exp Med Date: 2015-05-15

Review 5. CD20-negative diffuse large B cell lymphoma: a comprehensive analysis of 695 cases.

Authors: Jing Li; Shu Zhao; Jingxuan Wang; Jingyu Chen; Wen Wen; Qingyuan Zhang
Journal: Tumour Biol Date: 2015-10-12

Review 6. Review of the current targeted therapies for non-small-cell lung cancer.

Authors: Kim-Son H Nguyen; Joel W Neal; Heather Wakelee
Journal: World J Clin Oncol Date: 2014-10-10

Review 7. ALK-driven tumors and targeted therapy: focus on crizotinib.

Authors: Carlos Murga-Zamalloa; Megan S Lim
Journal: Pharmgenomics Pers Med Date: 2014-03-20

Review 8. Anaplastic lymphoma kinase-positive large B-cell lymphoma: Clinico-pathological study of 17 cases with review of literature.

Authors: Xiang-Nan Jiang; Bao-Hua Yu; Wei-Ge Wang; Xiao-Yan Zhou; Xiao-Qiu Li
Journal: PLoS One Date: 2017-06-30 Impact factor: 3.240

9. Diagnosis and treatment of pediatric anaplastic lymphoma kinase-positive large B-cell lymphoma: A case report.

Authors: Meng Zhang; Ling Jin; Yan-Long Duan; Jing Yang; Shuang Huang; Mei Jin; Guang-Hua Zhu; Chao Gao; Yi Liu; Nan Zhang; Chun-Ju Zhou; Zi-Fen Gao; Qin-Long Zheng; Dong Chen; Yong-Hong Zhang
Journal: World J Clin Cases Date: 2021-06-16 Impact factor: 1.337

10. Lenalidomide demonstrates clinical activity in anaplastic lymphoma kinase-positive large B-cell lymphoma.

Authors: Shakthi Bhaskar; Brooj Abro; Tyler J Fraum; Neha Mehta-Shah
Journal: BMJ Case Rep Date: 2020-08-25